BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 24313769)

  • 21. The lung microbiome and exacerbations of COPD.
    Dy R; Sethi S
    Curr Opin Pulm Med; 2016 May; 22(3):196-202. PubMed ID: 26964078
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Airway microbiome dynamics in exacerbations of chronic obstructive pulmonary disease.
    Huang YJ; Sethi S; Murphy T; Nariya S; Boushey HA; Lynch SV
    J Clin Microbiol; 2014 Aug; 52(8):2813-23. PubMed ID: 24850358
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New paradigms in the pathogenesis of chronic obstructive pulmonary disease II.
    Sethi S; Mallia P; Johnston SL
    Proc Am Thorac Soc; 2009 Sep; 6(6):532-4. PubMed ID: 19741263
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Systemic cytokine signaling via IL-17 in smokers with obstructive pulmonary disease: a link to bacterial colonization?
    Andelid K; Tengvall S; Andersson A; Levänen B; Christenson K; Jirholt P; Åhrén C; Qvarfordt I; Ekberg-Jansson A; Lindén A
    Int J Chron Obstruct Pulmon Dis; 2015; 10():689-702. PubMed ID: 25848245
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Microbial communities in the upper respiratory tract of patients with asthma and chronic obstructive pulmonary disease.
    Park H; Shin JW; Park SG; Kim W
    PLoS One; 2014; 9(10):e109710. PubMed ID: 25329665
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characteristics of the sputum microbiome in COPD exacerbations and correlations between clinical indices.
    Su L; Qiao Y; Luo J; Huang R; Li Z; Zhang H; Zhao H; Wang J; Xiao Y
    J Transl Med; 2022 Feb; 20(1):76. PubMed ID: 35123490
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The altered sputum microbiome profile in patients with moderate and severe COPD exacerbations, compared to the healthy group in the Indian population.
    Hazra D; Sm F; Chawla K; Sintchenko V; Martinez E; Magazine R; Siddalingaiah N
    F1000Res; 2023; 12():528. PubMed ID: 37928173
    [No Abstract]   [Full Text] [Related]  

  • 28. Bacterial microbiome of lungs in COPD.
    Sze MA; Hogg JC; Sin DD
    Int J Chron Obstruct Pulmon Dis; 2014; 9():229-38. PubMed ID: 24591822
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Understanding nontypeable Haemophilus influenzae and chronic obstructive pulmonary disease.
    Alikhan MM; Lee FE
    Curr Opin Pulm Med; 2014 Mar; 20(2):159-64. PubMed ID: 24441573
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Composition and dynamics of the respiratory tract microbiome in intubated patients.
    Kelly BJ; Imai I; Bittinger K; Laughlin A; Fuchs BD; Bushman FD; Collman RG
    Microbiome; 2016 Feb; 4():7. PubMed ID: 26865050
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The role of respiratory infection in exacerbation of chronic obstructive pulmonary disease].
    Dacydchenko SV; Bova AA
    Klin Med (Mosk); 2007; 85(5):10-5. PubMed ID: 17665597
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Involvement of the Innate Immune System in the Pathogenesis of Chronic Obstructive Pulmonary Disease.
    Kotlyarov S
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35055174
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The microbiome in the lower respiratory tract.
    Yatera K; Noguchi S; Mukae H
    Respir Investig; 2018 Nov; 56(6):432-439. PubMed ID: 30392534
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The lower airways microbiome and antimicrobial peptides in idiopathic pulmonary fibrosis differ from chronic obstructive pulmonary disease.
    Knudsen KS; Lehmann S; Nielsen R; Tangedal S; Haaland I; Hiemstra PS; Eagan TM
    PLoS One; 2022; 17(1):e0262082. PubMed ID: 34990493
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lower airway colonization and inflammatory response in COPD: a focus on Haemophilus influenzae.
    Finney LJ; Ritchie A; Pollard E; Johnston SL; Mallia P
    Int J Chron Obstruct Pulmon Dis; 2014; 9():1119-32. PubMed ID: 25342897
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of exacerbation phenotype with the sputum microbiome in chronic obstructive pulmonary disease patients during the clinically stable state.
    Yang CY; Li SW; Chin CY; Hsu CW; Lee CC; Yeh YM; Wu KA
    J Transl Med; 2021 Mar; 19(1):121. PubMed ID: 33757530
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lung microbiome composition and bronchial epithelial gene expression in patients with COPD versus healthy individuals: a bacterial 16S rRNA gene sequencing and host transcriptomic analysis.
    Ramsheh MY; Haldar K; Esteve-Codina A; Purser LF; Richardson M; Müller-Quernheim J; Greulich T; Nowinski A; Barta I; Stendardo M; Boschetto P; Korzybski D; Prasse A; Parr DG; Hohlfeld JM; Döme B; Welte T; Heath S; Gut I; Morrissey JA; Ziegler-Heitbrock L; Barer MR; Singh D; Brightling CE
    Lancet Microbe; 2021 Jul; 2(7):e300-e310. PubMed ID: 35544166
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lung microbiome mediates the progression from chronic obstructive pulmonary disease to lung cancer through inflammation.
    Wang YJ; Wu SS; Chu J; Kong XY
    Yi Chuan; 2021 Jan; 43(1):30-39. PubMed ID: 33509772
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diversity of Fungi and Bacteria in Bronchoalveolar Lavage Fluid during Development of Chronic Obstructive Pulmonary Disease.
    Wu X; Wei X; Li X; Deng J; Zhang J
    Jpn J Infect Dis; 2022 Nov; 75(6):560-568. PubMed ID: 35908874
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Systematic Review and Meta-Analysis of Sputum Purulence to Predict Bacterial Infection in COPD Exacerbations.
    Chen K; Pleasants KA; Pleasants RA; Beiko T; Washburn RG; Yu Z; Zhai S; Drummond MB
    COPD; 2020 Jun; 17(3):311-317. PubMed ID: 32456479
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.